This grant is for supporting bilateral research collaborations between U.S. and Indian institutions through Multiple Principal Investigator (Multi-PD/PI) applications. It aims to advance science and technology in understanding, preventing, and treating blinding eye diseases and visual disorders. Proposals are sought for basic biology, genetics, translational, or epidemiological research on ophthalmic conditions. These include diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, rare genetic diseases like congenital cataracts, ocular inflammation/uveitis, refractive error, and corneal injury. This initiative supports joint projects with Indian investigators, focusing exclusively on non-clinical trial research to address critical vision health challenges.
Opportunity ID: 334348
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-249 |
| Funding Opportunity Title: | India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.867 — Vision Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 25, 2021 |
| Last Updated Date: | Jun 25, 2021 |
| Original Closing Date for Applications: | Nov 08, 2023 |
| Current Closing Date for Applications: | Nov 08, 2023 |
| Archive Date: | Dec 14, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Small businesses County governments Native American tribal governments (Federally recognized) Independent school districts Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Special district governments State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications. Areas of Research Collaboration: Applications are encouraged from organization/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collaborations with Indian investigators on the following: diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, including rare and genetic diseases such as congenital cataracts, as well as other eye conditions such as ocular inflammation/uveitis, refractive error, low vision, and corneal injury. Basic, translational, or epidemiological research maybe proposed. Clinical trials will not be supported under this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-249.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334348 Full Announcement-PAR-21-249 -> PAR-21-249-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00267924 | Oct 08, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269811 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277758 | Nov 01, 2022 | Nov 08, 2023 | View |
Package 1
Mandatory forms
334348 RR_SF424_2_0-2.0.pdf
334348 PHS398_CoverPageSupplement_5_0-5.0.pdf
334348 RR_OtherProjectInfo_1_4-1.4.pdf
334348 PerformanceSite_2_0-2.0.pdf
334348 RR_KeyPersonExpanded_2_0-2.0.pdf
334348 PHS398_ResearchPlan_4_0-4.0.pdf
334348 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334348 RR_Budget_1_4-1.4.pdf
334348 RR_SubawardBudget30_1_4-1.4.pdf
334348 PHS398_ModularBudget_1_2-1.2.pdf
334348 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334348 RR_SF424_5_0-5.0.pdf
334348 PHS398_CoverPageSupplement_5_0-5.0.pdf
334348 RR_OtherProjectInfo_1_4-1.4.pdf
334348 PerformanceSite_4_0-4.0.pdf
334348 RR_KeyPersonExpanded_4_0-4.0.pdf
334348 PHS398_ResearchPlan_4_0-4.0.pdf
334348 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334348 RR_Budget_3_0-3.0.pdf
334348 RR_SubawardBudget30_3_0-3.0.pdf
334348 PHS398_ModularBudget_1_2-1.2.pdf
334348 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
334348 RR_SF424_5_0-5.0.pdf
334348 PHS398_CoverPageSupplement_5_0-5.0.pdf
334348 RR_OtherProjectInfo_1_4-1.4.pdf
334348 PerformanceSite_4_0-4.0.pdf
334348 RR_KeyPersonExpanded_4_0-4.0.pdf
334348 PHS398_ResearchPlan_5_0-5.0.pdf
334348 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334348 RR_Budget_3_0-3.0.pdf
334348 RR_SubawardBudget30_3_0-3.0.pdf
334348 PHS398_ModularBudget_1_2-1.2.pdf
334348 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
